Three years after buying a majority stake in Foundation Medicine for more than $1 billion as part of a research and development collaboration, Roche Pharmaceuticals has acquired the rest of the ...

Roche to acquire a majority interest in Foundation Medicine of up to 56.3% on a fully diluted basis through a tender and acquisition of newly issued shares. Roche will tender for approximately 15.6 ...

Today, Roche is the world's top supplier of cancer medicines, with oncology accounting for 53 percent of its drug sales. It is also a major manufacturer of drugs for transplantation patients, ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced the closing of its strategic transaction with Roche. This transaction included the purchase by Roche of ...

Roche in June bought out the rest of the cancer-genetics company Foundation Medicine that it didn't already own for $2.4 billion. It was the company's second cancer-data-related acquisition of the ...

Only months after a standstill agreement between the two companies expired, biopharma giant Roche Holdings (RHHBY 7.22%) has agreed to acquire Foundation Medicine (FMI) lock, stock, and barrel. Roche ...

Syapse, an oncology-focused precision medicine company, entered into a multiyear strategic collaboration with Roche. Syapse will work with Roche, which includes both pharmaceutical and diagnostics ...

Basel, 14 October 2013- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced plans to invest 800 million Swiss francs within its global manufacturing network to increase production capabilities for its ...

Roche is acquiring a major stake in Foundation Medicine, a laboratory that provides deep sequencing for individual patients' tumors. The Basel-based pharma said in January it will spend more than a ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) and Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that they will enter into a broad strategic collaboration to further ...

Only months after a standstill agreement between the two companies expired, biopharma giant Roche Holdings (NASDAQOTH: RHHBY) has agreed to acquire Foundation Medicine (NASDAQ: FMI) lock, stock, and ...